Session » Health Services Research
-
Abstract Number: 94
Possible Effects of Medicare-Only Insurance Coverage on the Use of Biologics in Patients with RA
-
Abstract Number: 96
Comparison of Cardiovascular Risk Factor Management in Patients with RA and Matched Non-RA Patients
-
Abstract Number: 98
Costs of Musculoskeletal Diseases in the United States, 1996-2011: Population Growth, Population Aging, Health Care Utilization, or Prices?
-
Abstract Number: 99
Impact of Comorbidities on Health Resource Utilization in Patients with Spa
-
Abstract Number: 100
Evaluation of Real World Experience with Non-Biologic DMARD in the Treatment of RA: Data from an Electronic Health Record Database
-
Abstract Number: 101
Country of Residence and Its Wealth Determine Disease Activity Levels in RA: Results from Multi-National Study Across 17 Countries (COMORA)
-
Abstract Number: 102
Real-World Utilization, Patient Characteristics and Persistency of Certolizumab Pegol Vs Other Anti-TNFs for the Treatment of Rheumatoid Arthritis in the United Kingdom
-
Abstract Number: 103
Rheumatology e-Consult Services: a Rheumatology Workforce Management Model
-
Abstract Number: 104
Reasons for Leaving an Academic Career in Research Among Rheumatologists in the United States
-
Abstract Number: 105
Resource Use and Health Related Quality of Life Burden of Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
-
Abstract Number: 106
Patient Reported Outcomes Following Upper Extremity Arthroplasties in RA -a Report from the Swedish National Register of Rheuma Surgery (RAKIR)
-
Abstract Number: 107
Use of Internet in Adolescents and Young Adults with JIA
-
Abstract Number: 108
Patient Reported Outcomes Following Total Knee Arthroplasty in Rheumatoid Arthritis and Osteoarthritis
-
Abstract Number: 109
Knee Arthroscopy in an International Training Centre: An Audit of Safety and Impact on Work Days
-
Abstract Number: 110
Use of Smartphones in Collecting Patient Reported Outcomes: Can Passively-Collected Behavior Determine Rheumatic Disease Activity? Early Results from a Nation-Wide Pilot Study
-
Abstract Number: 111
Low Rates of Bone Mineral Density Testing in Medicare Beneficiaries with Breast Cancer Starting Aromatase Inhibitor Therapy
-
Abstract Number: 112
Relationship Between Rheumatology Physician Supply and Travel Distances to Rheumatologists for Medicare Beneficiaries in the United States
-
Abstract Number: 113
Dermatologic Rheumatism: Our Experience with a Multidisciplinary Dermatology/Rheumatology Clinic
-
Abstract Number: 114
Treat-to-Target (T2T) and Measuring Outcomes in RA Care: a 2014 Longitudinal Survey of US Rheumatologists
-
Abstract Number: 115
Biologic Dmards Modify the Association Between Patient Expectations and Outcomes of Total Knee Replacement in Rheumatoid Arthritis Patients
-
Abstract Number: 116
Is Socioeconomic Status at Diagnosis Associated with Long-Term Direct Medical Costs in Systemic Sclerosis? a General Population-Based Cohort Study
-
Abstract Number: 117
Predictors of Gout Flares in a US Managed Care Setting
-
Abstract Number: 118
Difficult to Treat Gouty Arthritis Associated with Poor Health Related Quality of Life and High Resource Utilization: Post- Hoc Analysis
-
Abstract Number: 1141
Comparisons of Quality of Life, Resource Use and Physical Functioning in RA Patients Classified As High, Moderate or Low Risk for Rapid Radiographic Progression
-
Abstract Number: 1142
Healthcare Costs Associated with Serious Infections Among Biologic-Naïve Rheumatoid Arthritis Patients Initiating First-Line Biologic Treatment
-
Abstract Number: 1143
Preferences of Biologic Treatment Characteristics Among Rheumatoid Arthritis Patients Who Are Current Biologic Therapy Users
-
Abstract Number: 1144
Economic Implications for Policies Regarding Triple Therapy Use in Patients with Rheumatoid Arthritis
-
Abstract Number: 1145
Evaluation of Biologic Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Post-Tumor Necrosis Factor Inhibitor Discontinuation in Rheumatoid Arthritis
-
Abstract Number: 1146
Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
-
Abstract Number: 1147
Economic Implications of Flares Among Patients with Early Rheumatoid Arthritis (RA)
-
Abstract Number: 1148
Evaluation of a Methodological Approach to Determine Timing of Rheumatoid Arthritis Disease Onset Using Administrative Claims Data
-
Abstract Number: 1149
Novel Adherence Measures for Infusible Therapeutic Agents in Rheumatoid Arthritis
-
Abstract Number: 1150
Marked Differences in Euro-Qol-5-Dimensions Preference Sets Based on Hypothetical or Experience Based Valuation
-
Abstract Number: 1151
Barriers and Facilitators of a Career in Research Among Rheumatologists in the United States
-
Abstract Number: 1152
Euroqol-5-Dimensions Utility Gain in Rheumatoid Arthritis, Treated with Abatacept, Rituximab, Tocilizumab or Tumor Necrosis Factor Inhibitors
-
Abstract Number: 1153
Area of Residence and Socio-Economic Factors Significantly Affect Access to Biological Therapy for Rheumatoid Arthritis Patients in Romania
-
Abstract Number: 1154
Increasing Discrepancies Between Physician Assessment of Disease Activity and Patient Global Health in Germany Between 2000 and 2012
-
Abstract Number: 1155
Economic Impact of Frequent Gout Flares in a Managed Care Setting
-
Abstract Number: 1156
Satisfaction with Rural Rheumatology Telehealth Service
-
Abstract Number: 1157
Delay in Diagnosis from Onset of Symptoms By More Than One Year in 31% of Patients with Different Rheumatic Diseases in Australia
-
Abstract Number: 1158
A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence
-
Abstract Number: 1159
Long-Term Quality of Life, Productivity Impairment, Disease Severity and Health Care Costs in Relation to Functional Impairment in Ankylosing Spondylitis Patients in the Czech Republic
-
Abstract Number: 1161
The Price of a Positive Test: Is It Worth the Cost?
-
Abstract Number: 1162
Patterns of Use of Long-Term (> 5 Years) Oral Bisphophonate Prescription Among Primary Care Providers and Rheumatologists for the Treatment of Osteopenia and Osteoporosis in a Veteran Population
-
Abstract Number: 1163
Predictors of Cholesterol and Lifestyle Discussions in Rheumatoid Arthritis Visits: Impact of Perceived RA Control and Comparison with Other Prevention Topics
-
Abstract Number: 1164
Inequity: Level of Education Is Associated with Access to Biologic Dmards Even in a Country with Highly Developed Social Welfare (Norway)
-
Abstract Number: 1165
Evaluation of Symptom Control Among Treated Gout Patients in the United States, United Kingdom, and Germany
-
Abstract Number: 2103
Benefits of Early Onset of DAS28 (CRP) <2.6 on Physical Functioning, Quality of Life and Resource Use Among RA Patients in a Clinical Practice Setting
-
Abstract Number: 2104
Effectiveness of a Workplace Integrated Care Intervention on Work Productivity in Workers with Rheumatoid Arthritis
-
Abstract Number: 2105
Nonsurgical Treatment Patterns in Patients with Chronic Spinal Cord Injury
-
Abstract Number: 2106
Surgical Compared with Nonsurgical Management of Fractures in Men with Chronic Spinal Cord Injury
-
Abstract Number: 2107
Characterization of Social Stigma in Rheumatic Diseases and Correlation with Quality of Life and Medication Adherence
-
Abstract Number: 2108
Anxiety in Caregivers of Patients with Chronic Rheumatic Conditions
-
Abstract Number: 2109
Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in SLE?
-
Abstract Number: 2111
Overcoming Barriers to Acute Patient Access: Is There a Need for Urgent Care Clinics in Rheumatology Practices?
-
Abstract Number: 2112
Patterns of Medication Use Before, During, and After Pregnancy Among Women with Systematic Lupus Erythematosus: A Population-Based Study
-
Abstract Number: 2113
The Number of Morbidities Drives the Health Care Expenditures and Presence of a Musculoskeletal Condition Is Additionally Accountable for Higher Costs
-
Abstract Number: 2114
Comorbidity Characteristics of Patients Starting First-Line Acute Gout Agents – Colchicine, NSAID, and Corticosteroids
-
Abstract Number: 2115
Inflammatory Arthritis Treatment Outcomes at a First Nations Reserve Rheumatology Specialty Clinic
-
Abstract Number: 2116
Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012
-
Abstract Number: 2117
Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
-
Abstract Number: 2118
Lower Socioeconomic Status at Disease Onset Is Associated with Higher Health Care Costs in Patients with Systemic Lupus Erythematosus: A General Population-Based Cohort Study
-
Abstract Number: 2119
Off Work Days Decreased RATE in Muskuloeskeletal Disease Patients: Usefulness of the EARLY Intervention Program
-
Abstract Number: 2120
Societal Preferences for Rheumatoid Arthritis Treatments. Evidence from a Discrete Choice Experiment
-
Abstract Number: 2121
Real-World Cost Comparison of Urate Lowering Therapies in Patients with Gout and Moderate to Severe Chronic Kidney Disease
-
Abstract Number: 2122
Variation in the Prescribing Practices of Biologic Dmards
-
Abstract Number: 2123
Significant State-Level Variation in Source of Biologic Drug Coverage Among Beneficiaries with Rheumatoid Arthritis